EUVIMEDEUVIMED entdecken
Crossref

Establishment of a Carrot Cell Plant Growth Regulators-free System to Produce a Low-Cost Vaccine Candidate

Christian Carreño-Campos, Sahara Dubraiicka Elguea Zarate, Andrea Romero-Maldonado, María Luisa Villarreal, Sergio Rosales-Mendoza, Anabel Ortiz-Caltempa

Planta Medica · 01.10.2025 · 91 (12) · 656-663

DOI: 10.1055/a-2626-4703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.10.2025. Verfasst von Christian Carreño-Campos und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, México. Hauptthemen laut MEDLINE: Daucus carota, Vaccines. Die Arbeit nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parkinsonʼs disease is characterized by an abnormal accumulation of alpha synuclein (α-syn) in different regions of the central nervous system. At present, only palliative pharmacological treatments are available for Parkinson´s disease. Immunotherapy is considered an alternative to treat Parkinsonʼs disease, and plants are a convenient alternative platform for biopharmaceutical production. When compared to other systems, plants are particularly attractive because they offer cost-effectiveness, large-scale production, and enhanced safety. Therefore, this study aimed to establish a carrot cell suspension culture for the production of cLTB-Syn, a vaccine candidate against Parkinsonʼs disease. The convenience of MS medium optimization was demonstrated. Transgenic callus cultures were maintained and adapted on solid MSU9 medium without phytohormones, followed by growth kinetics in suspension cultures. The maximum biomass yield was 15.8 ± 0.35 g/L DW at 14 days of culture, with a growth rate of µ = 0.1034/d and td = 6.7 days. The cLTB-Syn protein production reached a maximum value of 2.62 ± 0.03 µg/g DW, representing a 1.6-fold increase over the initial culture time. Finally, the presence of the transgene was confirmed by PCR, and the integrity of cLTB-Syn protein was determined by dot blot assays. This study presents evidence of a promising system for a toxin-free biopharmaceutical production, which has the potential to be scaled up for large manufacturing, at a low cost.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Daucus carotaVaccinesPlants, Genetically ModifiedPlant Growth RegulatorsCell Culture TechniquesParkinson DiseaseCulture Media

Substanzen

Plant Growth RegulatorsVaccinesCulture Media

Autor:innen und Institutionen

  • Centro de Investigación en Biotecnología, Universidad Autónoma del Estado de Morelos, Cuernavaca, Morelos, México.
  • Sección de Biotecnología, Centro de Investigación en Ciencias de la Salud y Biomedicina (CICSaB), Universidad Autónoma de San Luis Potosí, San Luis Potosí (SLP), México.
  • Department of Pharmacognosy and Pharmaceutical Botany, Faculty of Pharmaceutical Sciences, Chulalongkorn University, Bangkok, Thailand.

Zitieren

APA

Carreño-Campos, C., Zarate, S. D. E., Romero-Maldonado, A., Villarreal, M. L., Rosales-Mendoza, S., & Ortiz-Caltempa, A. (2025). Establishment of a Carrot Cell Plant Growth Regulators-free System to Produce a Low-Cost Vaccine Candidate. Planta Medica, 91(12), 656-663. https://doi.org/10.1055/a-2626-4703

Vancouver

Carreño-Campos C, Zarate SDE, Romero-Maldonado A, Villarreal ML, Rosales-Mendoza S, Ortiz-Caltempa A. Establishment of a Carrot Cell Plant Growth Regulators-free System to Produce a Low-Cost Vaccine Candidate. Planta Medica. 2025;91(12):656-663. doi:10.1055/a-2626-4703

BibTeX
@article{CarreoCampos2025,
  author = {Carreño-Campos, Christian and Zarate, Sahara Dubraiicka Elguea and Romero-Maldonado, Andrea and Villarreal, María Luisa and Rosales-Mendoza, Sergio and Ortiz-Caltempa, Anabel},
  title = {Establishment of a Carrot Cell Plant Growth Regulators-free System to Produce a Low-Cost Vaccine Candidate},
  journal = {Planta Medica},
  year = {2025},
  volume = {91},
  number = {12},
  pages = {656--663},
  doi = {10.1055/a-2626-4703}
}
Kostenlos starten →